Merck KGaA, Darmstadt, Germany, Finishes Year of Key Strategic Moves with Record Figures

"In 2014 we have laid the foundations for future growth,” said Karl-Ludwig Kley, Chairman of the Executive Board. “The company is transforming into a highly specialized, global technology company with the goal to improve the lives of patients and customers.”

Kley in Davos

More than 2,500 participants from the worlds of business, politics, science and culture as well as representatives of international organizations attended the annual meeting of the World Economic Forum this week. Besides discussing topics that Merck KGaA, Darmstadt, Germany, can make a positive contribution to, CEO Karl-Ludwig Kley shared his views on current economic challenges and the future development of Merck KGaA, Darmstadt, Germany, in various media interviews.

Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology

November 17, 2014 – Merck KGaA, Darmstadt, Germany, and Pfizer entered into a global agreement to co-develop and co-commercialize our investigational anti-PD-L1 antibody as a potential treatment for multiple tumor types to accelerate the two companies’ presence in immuno-oncology.
As part of the agreement, Merck KGaA, Darmstadt, Germany, will co-promote Pfizer’s Xalkori, a medicine to treat non-small cell lung cancer, in the United States and several other key markets.

 

Media Services for the US and Canada – News starting 2013, Dates & Publications

Latest Press Releases
Kai Beckmann - Member of the Executive Board
Kai Beckmann - Member of the Executive Board
Employees of Merck KGaA, Darmstadt, Germany, Benefit From Company Success
Darmstadt, Germany, March 4, 2015 – With a total of € 300 million, Merc KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, will reward its employees worldwide for the economic success of the year 2014. As Merck KGaA, Darmstadt, Germany, announced today, this is the highest sum ever paid in bonuses.
 
Merck KGaA, Darmstadt, Germany, Finishes Year of Key Strategic Moves with Record Figures
Merck KGaA, Darmstadt, Germany, Finishes Year of Key Strategic Moves with Record Figures
Darmstadt, Germany, March 3, 2015 – "In 2014 we have laid the foundations for future growth,” said Karl-Ludwig Kley, Chairman of the Executive Board. “The company is transforming into a highly specialized, global technology company with the goal to improve the lives of patients and customers.”
 
Merck KGaA, Darmstadt, Germany, Strengthens Presence as Leading Oncology Company by Taking Full Promotional Responsibility for Erbitux in Japan
Merck KGaA, Darmstadt, Germany, Strengthens Presence as Leading Oncology Company by Taking Full Promotional Responsibility for Erbitux in Japan
Darmstadt, Germany, February 13, 2015 – Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials today announced that Merck KGaA, Darmstadt, Germany, and Bristol-Myers Squibb have agreed to transfer full responsibility for the promotion of Erbitux® (cetuximab) to Merck KGaA, Darmstadt, Germany, in Japan as of May 1, 2015.
 
 
top

OUR COMPANY IN THE MEDIA

OUR COMPANY IN THE MEDIA
Read how Merck KGaA, Darmstadt, Germany, and its affiliates are covered by media outlets around the world

DOWNLOAD LIBRARY

Download Library
Download images, Media Kits and other material from our media download library

CALENDAR OF EVENTS

Calendar of Events
Find and register for upcoming events

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
In the United States and Canada the subsidiaries of Merck KGaA, Darmstadt, Germany, operate under the umbrella brand EMD.
 

CONTACTS FOR JOURNALIST INQUIRIES

Media Team
POSTAL ADDRESS 
Merck KGaA 
Frankfurter Straße 250 
64293 Darmstadt 
Germany
Tel.: +49 6151 72-5000
Fax: +49 6151 72-3138
 

GENERAL INQUIRIES

Communications Center
Tel.: +49 6151 72-0
Fax: +49 6151 72-2000
 

ANNUAL REPORT 2014

Financial Report
Merck on Facebook
Merck on Twitter
 
  
Read more on M - The Explorer Magazine

A startup workshop gets ideas rolling

On the bus heading from Tanzania to Rwanda are 37 young people. This is not a pleasure trip - it is a startup workshop on wheels that is supported by many companies including us.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

Patients as heroes

Participants in clinical trials play a key role in medical progress. Our company expressly appreciates their commitment and relies on this partnership, which is based on close collaboration.

Read more on M - The Explorer Magazine